Chenguang Biotech Group Co.,Ltd.’s Net Profit Rose 30.7% in First Three Quarters of 2022

Chenguang Biotech Group Co.,Ltd. (晨光生物科技集团股份有限公司) (300138.SZ) reported a net profit of 338.5 million yuan in the first three quarters of 2022, up 30.7% year-on-year.

Meanwhile, the company posted 4.8 billion yuan in revenue, up 49.6% year-on-year.

At the end of the reporting period, it had 6.5 billion yuan in total assets and 3.4 billion yuan in total liabilities, with a liability-to-asset ratio of 51.9%.